Atlas Trials

Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC

Clinical trial NCT01024829 · UNKNOWN

Trial details

NCT number
NCT01024829
Sponsor
The Netherlands Cancer Institute
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
NSCLC
Start date
2010-05-01
Primary completion
2020-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.